Shares in Eurofins Scientific SE do not show any sign of a slowdown in the ascending dynamic. Investors could bet on a continuation of the underlying trend. Investors have an opportunity to buy the stock and target the € 88.49.
The group usually releases upbeat results with huge surprise rates.
Over the past year, analysts have regularly revised upwards their sales forecast for the company.
For the last week, the earnings per share forecast has been revised upwards. According to recent estimates, analysts give a positive overview of the stock
For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
The tendency within the weekly time frame is positive above the technical support level at 68.63 EUR
Stock prices approach a strong long-term resistance in weekly data at EUR 88.21.
With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
With a 2021 P/E ratio at 29.8 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
The company is not the most generous with respect to shareholders' compensation.
Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.